eNose in Colorectal Cancer.

Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT). Part 5: Diagnostic value of the eNose in Colorectal Cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24427

Enrollment

Registered

2010-07-22

Start date

2010-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients (18-80 yr) with histological confirmed CRC ( 20 patients) will be included in the analysis of the present study; 20 healthy controls, matched with the CRC patients for sex, age and smoking status, who had normal findings at colonoscopy performed for various reasons. Inclusion criteria: 1. Written informed consent obtained; 2. Colorectal cancer: A. Adult 18-80 years; B. Histological proven CRC. 3. Controls, matched for: A. Age: 3 months; ii. Current smoker or ex-smoker < 3 months. C. Sex; D. Normal findings at colonoscopy performed for various reasons like e.g. irritable bowel syndrome and familial adenomatous polyposis.

Exclusion criteria

Exclusion criteria: 1. Periodontitis; 2. Any infection (especially of the airways) in the last 4 weeks; 3. Known pulmonary disease; 4. Other or former malignancy; 5. Diabetes mellitus (documented in the past); 6. Pregnancy; 7. Untreated hypercholesterolaemia (documented in the past); 8. Significant cardiovascular disease (documented in the past); 9. Healthy controls: Any abnormal findings at colonoscopy (e.g. like polyps).

Design outcomes

Primary

Measure	Time frame
Breathprint of electronic nose.	—

Contacts

Public ContactJ. Maten, van der

Dept. of pulmonary diseases MCL Leeuwarden

j.maten@znb.nl+31 (0)58 286 6190

Outcome results